Siemens presents new E.Cam cardiac unit
Siemens Medical Systems' nuclear medicine group of Hoffman Estates, IL, rolled into the Radiological Society of North America meeting last month with a new offering in its E.Cam line. The company introduced E.Cam Cardiac Imaging System for dedicated
Siemens Medical Systems' nuclear medicine group of Hoffman Estates, IL, rolled into the Radiological Society of North America meeting last month with a new offering in its E.Cam line. The company introduced E.Cam Cardiac Imaging System for dedicated cardiac SPECT applications and cardiac perfusion studies. The new camera is part of the group's ongoing effort to reach market niches by segmenting its gamma camera lineup.
The new E.Cam has detector heads that can be positioned in both 90 and 76 configurations for automatic body contouring, and its cardiology software package includes the Advanced Emory Cardiac Toolbox. Like other E.Cams, it employs a workstation based on Apple's Macintosh G3 computer.
The cardiac system adds a fifth camera to the company's other E.Cam offerings: a variable-angle system, a dual-head, 180 unit, a single-head camera, and a coincidence unit. Siemens expects the new E.Cam to list in the $280,000 to $340,000 range.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.
